skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines beractantQuestion & answer

beractant · Medicine question

What pharmaceutical form is Survanta (beractant) 25 mg/ml?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Survanta (beractant) 25 mg/ml is a sterile suspension for intratracheal administration.

Sources for this answer

Survanta 25mg/ml suspensionAbbVie Ltd · emc · SmPC §3 Pharmaceutical form · Version 14Document updated 23 July 2020

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

beractant

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about beractant

Are effects on driving and using machines relevant to beractant (Survanta)?Can oxygen desaturation occur during administration of beractant (Survanta)?Has antibody production against Survanta (beractant) proteins been observed?Have any incompatibilities been experienced with Survanta (beractant) suspension?Have blood levels and plasma half-life been studied for beractant (Survanta)?How does beractant (Survanta) act on the lungs?

Read the beractant guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX